GlassScriptPhysician profile
Nathan A Nicholson
NPI 1972860476
$1,842.66
in general payments reported to CMS, 2019-2025
8 companies · $454 in 2025
The $454 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $12.14 · 2021: $50.03 · 2023: $775 · 2024: $398 · 2025: $454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $962 · Food and Beverage: $665.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $962.11 |
| Food and Beverage | $665.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $1,041.82 | 2019-2025 | Actis, Na, Lcp |
| Stryker Corporation | $475.82 | 2019-2025 | Mako, Triathlon, Accolade |
| Medical Device Business Services, INC. | $102.71 | 2019-2023 | Attune |
| Zimmer Biomet Holdings, INC. | $87.79 | 2025 | Mymobility Platform, Persona |
| Prism Medical | $84.71 | 2024-2025 | |
| Anika Therapeutics, INC. | $20.23 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $17.44 | 2024 | Exparel, Zilretta, Iovera |
| Sanofi-Aventis U.S. LLC | $12.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Nicholson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.